SXTP 60 Degrees Pharmaceuticals, Inc.

1.100USD-0.90%Mkt Cap: 3.87M $P/E: —

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers …

Key Statistics

Company
Market Cap3.87M USD
Enterprise Value12.51M USD
Revenue (TTM)1.21M USD
Gross Profit223.78K USD
Net Income (TTM)-7.37M USD
Revenue/Share0.76 USD
Last Price1.100 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.31
PEG—
EV/EBITDA-1.47
EV/Revenue10.30
P/S3.21
P/B-0.42
EPS (TTM)-5.34
EPS (Forward)-3.58
52W Range
0.86003% of range8.620
52W High8.620 USD
52W Low0.8600 USD
Profitability
Gross Margin22.26%
Oper. Margin-1092.41%
EBITDA Margin0.00%
Profit Margin-732.51%
ROE-212.67%
ROA-137.25%
Growth
Revenue Growth-32.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.85M USD
CapEx (TTM)218.08K USD
FCF Margin-500.54%
FCF Yield-157.19%
Net Debt-871.43K USD
Net Debt/EBITDA0.10
Balance Sheet
Debt/Equity0.04
Current Ratio2.33
Quick Ratio0.99
Book Value/Sh-2.62 USD
Cash/Share0.29 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJan 20, 2026
Analyst Consensus
Rating—
Target (Mean)3.700 USD
Upside (mean)+236.4%
Target Range3.700 USD – 3.700 USD
# Analysts1
Ownership
Shares Out.3.52M
Float2.44M
Insiders19.39%
Institutions17.11%
Short Interest
Short Ratio3.7d
Short % Float6.18%
Short % Out.6.14%
Shares Short215.99K
Short (prev mo.)277.18K
Technical
SMA 501.126 (-2.3%)
SMA 2001.918 (-42.6%)
Beta2.40
S&P 52W Chg16.45%
Avg Vol (30d)171.61K
Avg Vol (10d)151.33K
Technical Indicators
RSI (14)46.7
MACD0.0345
MACD Signal0.0174
MACD Hist.+0.0171
BB Upper1.457 USD
BB Middle1.100 USD
BB Lower0.7441 USD
BB Width64.76%
ATR (14)0.1547 USD
Vol Ratio (20d)0.68x